Knowde Enhanced TDS
Identification & Functionality
- Ingredient Origin
- Cosmetic Ingredients Functions
- Technologies
- Product Families
Features & Benefits
- Benefit Claims
- Labeling Claims
- Product Benefits
- 100% all natural; plant derived
- Broad spectrum innovative cosmetic preservative
- Synergistic blend of plant derived lipoamino acids
- Globally approved
- Stable to high temperature, pH and hydrolysis
- Effective in acidic pH
- Whole Foods Premium Compliant
- Mode of Action
AE PureProtek® is the combination of plant derived Glycine Lipoaminoacids. The result is a broad spectrum, potent system for preservation of cosmetic products. The Glycine Lipoaminoacids structure in combination is able to penetrate the bacterial cell wall and enable to effectively kill the bacteria. The combination makes the mixture very effective in
penetration of the cell membrane of microorganism resulting to optimized anti-microbial efficacy.- Microbiological Efficacy
AE PureProTek® has a broad spectrum efficacy against Gram Positive, Gram Negative, Yeast and Fungi.
Applications & Uses
- Markets
- Applications
- Application Format
- Effective Use Level
Leave-on/Rinse-off products pH 6: 1.75%
- User Guide
- Emulsions: Use at the level of 1.5% to 1.75%,AE PureProtek® can be added in hot water phase just before emulsification.
- Clear Solutions: AE PureProtek® can be solubilized to make clear products.
- Wet wipes: AE PureProtek® good preservation results are achieved at level 1.5% to 1.75%
Properties
- Odor
- Characteristic
- Appearance
- White powder
- Soluble in
- Water (at 60°C)
- Physico-Chemical Properties
- Microbiological Values
| Value | Units | Test Method / Conditions | |
| Specific Weight | 500 -700 | g/l | — |
| Flash Point | min. 100 | ºC | DIN 51 758 |
| Value | Units | Test Method / Conditions | |
| Aspergillus niger | min. 0.4 | % | — |
| Burkholderia cepacia | min. 0.7 | % | — |
| Candida albican | min. 0.6 | % | — |
| Enterobacter cloacae | min. 0.6 | % | — |
| Escherichia coli | min. 0.6 | % | — |
| Klebisella pneumonia | min. 0.6 | % | — |
| Penicillium funiculosum | min. 0.4 | % | — |
| Pseudomonas aeruginosa | min. 0.6 | % | — |
| Pseudomonas fluorescens | min. 0.6 | % | — |
| Pseudomonas putida | min. 0.6 | % | — |
| Staphylococcus aureus | min. 0.6 | % | — |
| Staphylococcus epidermidis | min. 0.5 | % | — |
Regulatory & Compliance
- Certifications & Compliance
- Worldwide Approval
Approved for use in China, Japan, Canada and Australia